A detailed history of Legal & General Group PLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 6,279 shares of PRME stock, worth $21,725. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,279
Previous 4,336 44.81%
Holding current value
$21,725
Previous $30,000 6.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.3 - $8.03 $8,354 - $15,602
1,943 Added 44.81%
6,279 $32,000
Q4 2023

Feb 15, 2024

SELL
$5.59 - $9.55 $1,050 - $1,795
-188 Reduced 4.16%
4,336 $38,000
Q3 2023

Nov 14, 2023

SELL
$9.5 - $15.07 $2,536 - $4,023
-267 Reduced 5.57%
4,524 $43,000
Q2 2023

Aug 14, 2023

BUY
$11.41 - $17.05 $15,563 - $23,256
1,364 Added 39.8%
4,791 $70,000
Q1 2023

May 15, 2023

BUY
$11.21 - $21.11 $28,047 - $52,817
2,502 Added 270.49%
3,427 $42,000
Q4 2022

Feb 14, 2023

BUY
$15.2 - $21.12 $14,060 - $19,536
925 New
925 $17,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $331M
More about PRME
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.